![]() |
![]() |
||
|
|
||
Daniel Mikol Ph.D. |
|||
| Assistant Professor | |||
Department of Neurology |
|||
|
|||
734-763-7270 |
|||
Our laboratory is studying the molecular mechanisms of myelination. There are two major areas of research in the lab: 1) Caveolin-1 regulation of oligodendrocyte signal transduction, proliferation, differentiation, cell death, and phenotype 2) The function of OMgp, a lipid-linked myelin glycoprotein inhibitor of neurite outgrowth and obstacle to neural repair.
|
|||
Mikol DD, Hong HL, Cheng H-L, Feldman EL. Caveolin-1 expression in Schwann cells. Glia 27, 39-52, 1999. Mikol DD and Feldman EL. Neurophilins and the nervous system. Muscle and Nerve 22 (10), 1337-1340, 1999. Mikol DD. Treat Early, but Treat Hard: Interferon-beta dose makes a difference. J. Neuroophth. 21 (4), 237-9, 2001. Mikol DD, Scherer, SS, Kim S, Hong HL, Duckett SJ, Feldman EL. Schwann cell caveolin-1 expression increases during myelination and decreases following axotomy. Glia 38: 191-199, 2002. Kottis, V, Thibault P, Mikol DD, Xiao Z-C, Zhang R, Derghan P, Braun PE. Oligodendrocyte-myelin glycoprotein is an inhibitor of neurite outgrowth. J. Neurochem. 82: 1566-1569, 2002.
Find more publications by Dr.Daniel Mikol |
|||
| Last updated 11/7/2004 Click here to update | |||